About Clinical Trial Results
Clinical Trial Results provides a unique data-driven venue for rapid peer-reviewed publication in a condensed format that distills trials to their key features.
- * Trials with straightforward study designs;
- * Trials that did not meet primary outcome endpoints but that warrant online access in the global literature;
- * Studies that did not complete accrual because of toxicity, logistics, etc., but for which publication of gathered data is part of Good Clinical Practice (GCP);
- * Data from Phase I, -II, and/or -III trials.
Read the Frequently Asked Questions and Submission Steps here: http://theoncologist.alphamedpress.org/site/misc/CTR_SubmissionProcessStepsandFAQ.pdf
View the entire collection of published CTRs here: http://theoncologist.alphamedpress.org/site/misc/PublishedClinicalTrialResults.xhtml
- A brief Author Summary, to be published in print. This summary allows the reader to quickly grasp the aim and design of the study. It is made up of a structured abstract (200 words or less) containing four sections: Background, Methods, Results, and Conclusion; followed by a brief Discussion. This Discussion can take one of two forms:
- 350 words and two salient graphics, such as a table, schema, waterfall plot, image or graph
- 450 words with a single salient graphic
- The full data set, incorporating all supporting documentation and an extended Discussion, to be published online. Authors are allowed 1000 words for the extended online Discussion; they are encouraged to be thorough, yet concise. The sponsor, coordinating site, participating sites, and investigators should all be clearly identified.
The data published online remains the property of the author(s).
The Author Summary and the full Clinical Trial Results share a title and are PubMed citable with their own DOI (Document Object Identifier).
Join the mission of improving clinical trial design and efficiency by submitting results today.